The Latest Cardiac and Vascular News
MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing 10.0 percent on a reported basis, 12.6 percent on an operational1 basis and 9.7 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income […]
IRVINE, Calif., April 26, 2022 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2022. First Quarter Highlights and Outlook Q1 sales grew 10 percent to $1.34 billion; underlying1 13 percent Q1 TAVR sales grew 11 percent; underlying 14 percent Q1 EPS was $0.59; adjusted1 EPS was $0.60 Full year 2022 financial […]
Studies Showed Sustained Reduction in LDL-C With no new Safety Findings The Combined Studies Evaluated Safety and Tolerability of Repatha in More Than 6,600 Patients for Over Five Years After Completing the Phase 3 FOURIER Trial Repatha is the Longest Studied PCSK9i THOUSAND OAKS, Calif., April 27, 2022 /PRNewswire/ — Amgen (NASDAQ:AMGN) […]
Series A funding round will accelerate international expansion and fuel AI-based medical algorithm development. CAMBRIDGE, Mass., April 27, 2022 /PRNewswire/ — IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, today announced it has raised $23 million in Series A funding led by new investors: Crédit Mutuel Innovation and Bpifrance. Additional investors […]
STOCKHOLM, April 27, 2022 /PRNewswire/ — A strong start for the year with continued overall growth Our strong finish of 2021 is now followed by a first quarter of 2022 with considerable growth for both order intake and net sales. We increased the order book to 91.4 (72.9) MSEK compared to the end […]
BOSTON, April 27, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) has established a new sister organization: the ISHLT Foundation. This new entity serves as the charitable arm of ISHLT, and will fund a global portfolio of research grants and fellowship awards to improve patient care for advanced heart […]
– Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress – MARSEILLE, France and PROVIDENCE, R.I., April 27, 2022 (GLOBE NEWSWIRE) — Volta Medical, a pioneering medtech startup advancing novel artificial intelligence (AI) algorithms to treat cardiac arrhythmias, today announced it […]
Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the patented technology platform built around BAPAIs Quantum Genomics is taking this opportunity to strengthen and expand its shareholder structure PARIS, April 27, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth […]
Thrombolytics in target lesion were not used for 19 of 20 patients treated with next-generation mechanical arterial thrombectomy device EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ : SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that its Pounce™ Thrombectomy System […]
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2022 second quarter ended March 31, 2022 and updated its financial outlook for its fiscal 2022. Summary of Second Quarter and Recent […]
